Generic Semaglutide to Slash Weight-Loss Drug Costs by 90% in India
Generic versions of injectable semaglutide will launch in India from March 21, reducing therapy costs by up to 90%. This follows Novo Nordisk's patent expiry, with Natco Pharma and Eris Lifesciences leading the price war.


